Address
Rue Edouard Belin 12
Mont-Saint-Guibert, WA 1435
Belgium
Phone
32 1 022 23 55
Website
Sector
Healthcare
Industry
Medical - Specialties
Employees
163
First IPO Date
April 28, 2021
| Name | Title | Pay | Year Born |
| Olivier Taelman | Chief Executive Officer & Executive Director | 998,081 | 1972 |
| Robert Taub | Co-Founder & Chairman | 135,551 | 1947 |
| Loic Moreau | President of International | 535,845 | 1980 |
| Bruno Onkelinx | Chief Technical Officer | 1.71M | 1972 |
| Jeyakumar Subbaroyan | Chief Science Officer | 0 | N/A |
| John Landry | Chief Financial Officer | 0 | 1973 |
| Geeta Kaveti | Chief Compliance Officer | 0 | N/A |
| Maggie McGowan | Chief HR Officer | 0 | N/A |
| An Moonen | General Counsel | 0 | N/A |
| Pearson Dennis | Investor Relations Associate | 0 | N/A |
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.